Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice
Renaud Louis, Gilles Louis, Olivier Bonhomme
Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Renaud Louis, Gilles Louis, Olivier Bonhomme. NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice. Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Expert interview on ERS Guidelines for the diagnosis of asthma in adults
Eosinophils and airway nerves in asthma
Related content which might interest you:
The future of disease monitoring and management: the homework for clinical researchers
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Underrepresentation of patients with cardiovascular diseases in trials of chronic obstructive pulmonary disease: Transferability problems in general practice?
Source: Annual Congress 2010 - Management of airway disease
The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases?
Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly
Source: Eur Respir J 2003; 21: 3S-9S
Biomarkers of airways inflammation in patients with severe asthma in a real clinical practice
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice
Source: Eur Respir J 2013; 41: 1252-1256
The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study
Source: Virtual Congress 2020 – Investigations of COPD
Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label
Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017
Patients and families realizing their future with chronic obstructive pulmonary disease - a qualitative study
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice
Source: Breathe, 16 (1) 889; 10.1183/20734735.0301-2019
How to increase the value of randomised trials in COPD research
Source: Eur Respir J 2009; 34: 552
How to screen chronic obstructive pulmonary disease in general practice?
Source: International Congress 2015 – Respiratory disease management in primary care
Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 243-244
Differentiating asthma from chronic obstructive pulmonary disease (COPD) in medico-economic databases: myth or reality?
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): A two-year study
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study
Source: Eur Respir J 2009; 34: 588